Highland Capital Management Fund Advisors, L.P. Organogenesis Holdings Inc. Transaction History

Highland Capital Management Fund Advisors, L.P.

$846 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$14.92 - $23.23 $298,400 - $464,600	-20,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.63 - $7.53 $72,600 - $150,600	20,000 New	20,000 $151,000

Others Institutions Holding ORGO

# of Institutions

118

Shares Held

64.3M

Call Options Held

25K

Put Options Held

23.2K

Morgan Stanley New York, NY

12M
Shares

$40 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

11.8M
Shares

$39.5 Million
2.88% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$17 Million
0.0% of portfolio
Deutsche Bank Ag\ Frankfurt Am Main, 2M

4.84M
Shares

$16.2 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

3.67M
Shares

$12.3 Million
0.0% of portfolio

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $437M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account